Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00941031
What this trial is testing

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 404
Post-approval studies (Phase 4)UnknownNCT03408756
What this trial is testing

Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis

Who this might be right for
Psoriasis Vulgaris
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Testing effectiveness (Phase 2)Study completedNCT01483924
What this trial is testing

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
ApoPharma 60
Not applicableStudy completedNCT04275024
What this trial is testing

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Effect+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 8
Large-scale testing (Phase 3)Study completedNCT00109317
What this trial is testing

Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy

Who this might be right for
Psoriasis
Genentech, Inc. 686
Not applicableStudy completedNCT04894890
What this trial is testing

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 1,002
Testing effectiveness (Phase 2)Study completedNCT03265613
What this trial is testing

Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Toxicity+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 7
Large-scale testing (Phase 3)Active Not RecruitingNCT06425549
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 176
Post-approval studies (Phase 4)Study completedNCT03403036
What this trial is testing

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Who this might be right for
Psoriasis
Icahn School of Medicine at Mount Sinai 39
Testing effectiveness (Phase 2)Looking for participantsNCT07204639
What this trial is testing

Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects

Who this might be right for
Psoriasis
Clarent Biopharma, Inc. 100
Testing effectiveness (Phase 2)WithdrawnNCT03298581
What this trial is testing

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited
Post-approval studies (Phase 4)Study completedNCT00581165
What this trial is testing

Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept

Who this might be right for
Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 500
Large-scale testing (Phase 3)Looking for participantsNCT07116967
What this trial is testing

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 3,040
Large-scale testing (Phase 3)Study completedNCT02394561
What this trial is testing

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

Who this might be right for
Plaque Type Psorisis
Novartis Pharmaceuticals 434
Large-scale testing (Phase 3)Ended earlyNCT00358670
What this trial is testing

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 441
Testing effectiveness (Phase 2)Study completedNCT00245765
What this trial is testing

Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy

Who this might be right for
Chronic Plaque Psoriasis
UCB Pharma 176
Large-scale testing (Phase 3)Study completedNCT00647400
What this trial is testing

Adalimumab in Adult Japanese Subjects With Psoriasis

Who this might be right for
Psoriasis
Abbott 147
Large-scale testing (Phase 3)Study completedNCT05536726
What this trial is testing

Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 458
Testing effectiveness (Phase 2)Study completedNCT03431974
What this trial is testing

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

Who this might be right for
Psoriasis
Syntrix Biosystems, Inc. 19
Not applicableStudy completedNCT04433442
What this trial is testing

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie 2,324
Next Page